NCT05991193 A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
| NCT ID | NCT05991193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hunan Province Tumor Hospital |
| Condition | NSCLC |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-29 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-12-29 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Eligibility Criteria
Inclusion Criteria: * Patients must be ≥18 years. * Provision of fully informed consent prior to any study specific procedures. * Patient with EGFR 19Del or L858R mutation diagnosed histologically or cytologically. The mutations above may exist alone or together. * Patients must have untreated advanced Non-Small Cell Lung Cancer (NSCLC). * According to the RECIST 1.1 standard, the patient must have at least one measurable lesion. Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05991193 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying NSCLC. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05991193 currently recruiting?
Yes, NCT05991193 is actively recruiting participants. Contact the research team at zhangyongchang@csu.edu.cn for enrollment information.
Where is the NCT05991193 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT05991193 clinical trial?
NCT05991193 is sponsored by Hunan Province Tumor Hospital. The trial plans to enroll 100 participants.